PRF Technologies (PRFX) Accounts Payables (2019 - 2025)
PRF Technologies' (PRFX) quarterly Accounts Payables came in at $213000.0 in Q4 2025, down 28.04% YoY from $296000.0 in Q4 2024, and up 29.88% on a QoQ basis from $164000.0 in Q2 2025.
PRF Technologies (PRFX) Accounts Payables (2019 - 2025) Analysis & Trends
PRF Technologies (PRFX) has 7 years of Accounts Payables data on file, last reported at $213000.0 in Q4 2025.
- Quarterly Accounts Payables fell 28.04% year-over-year to $213000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $213000.0 (down 28.04% YoY) and the FY2025 annual result came in at $213000.0, down 28.04% from the prior year.
- Accounts Payables climbed to $213000.0 in Q4 2025, from $164000.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $385000.0 in Q3 2022 to a low of $57000.0 in Q2 2021.
- A 5-year average of $195882.4 and a median of $209000.0 in 2022 frame the typical range for Accounts Payables.
- The widest YoY moves for Accounts Payables: up 338.46% in 2021, down 81.11% in 2021.
- Tracing PRFX's Accounts Payables over 5 years: stood at $136000.0 in 2021, then jumped by 53.68% to $209000.0 in 2022, then slumped by 66.99% to $69000.0 in 2023, then surged by 328.99% to $296000.0 in 2024, then retreated by 28.04% to $213000.0 in 2025.
- The last three Accounts Payables figures came in at $213000.0 (Q4 2025), $164000.0 (Q2 2025), and $296000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - | 213,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 213,000.00 |
| Jun 30, 2025 | 164,000.00 |
| Dec 31, 2024 | 296,000.00 |
| Jun 30, 2024 | 119,000.00 |
| Mar 31, 2024 | 209,000.00 |
| Dec 31, 2023 | 69,000.00 |
| Sep 30, 2023 | 214,000.00 |
| Jun 30, 2023 | 70,000.00 |
| Mar 31, 2023 | 313,000.00 |
| Dec 31, 2022 | 209,000.00 |
| Sep 30, 2022 | 385,000.00 |
| Jun 30, 2022 | 212,000.00 |
| Mar 31, 2022 | 334,000.00 |
| Dec 31, 2021 | 136,000.00 |
| Sep 30, 2021 | 171,000.00 |
| Jun 30, 2021 | 57,000.00 |
| Mar 31, 2021 | 159,000.00 |
| Dec 31, 2020 | 720,000.00 |
| Jun 30, 2020 | 13,000.00 |
| Dec 31, 2019 | 166,000.00 |